Transgene

Stocks

Market Closed - Euronext Paris Other stock markets 16:55:00 29/07/2026 BST			5-day change	1st Jan Change
0.7160 ^EUR	-0.28%		-1.51%	-25.42%

06-29	Transgene SA - Special Call
06-25	Oddo BHF Stays Positive on Transgene

Published on 06/29/2026 at 03:35 pm BST - Modified on 06/29/2026 at 09:52 pm BST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good morning, and welcome to the Transgene virtual key opinion leader event. At this time, all attendees are in a listen-only mode and a

[

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

06-29	Transgene SA - Special Call
06-25	Oddo BHF Stays Positive on Transgene
06-25	Positive Preclinical Data for a Transgene Vaccine
06-25	Transgene Presents Preclinical Data Demonstrating Robust Protection Against Mpox With Its Novel Scalable Cell Line?Derived MVA Vaccine Candidate TG-MVATM	CI
06-22	Transgene Expands myvac® into Non-Small Cell Lung Cancer with TG4070, an Individualized Neoantigen Therapeutic Vaccine	CI
06-22	Transgene launches a clinical trial evaluating TG4070 with nivolumab
06-22	Transgene Begins Phase 1 Trial of Non-small Cell Lung Cancer Vaccine	MT
05-22	Transgene SA Announces Board Appointments	CI
04-13	Transgene Completes Patient Randomization in Phase 2 Clinical Trial Evaluating TG4050 in Adjuvant Treatment of Head and Neck Cancer	CI
04-07	Transgene stands out following licensing agreement with NEC Bio
04-03	Transgene, NEC Bio Enter Partnership to Develop Cancer Vaccine	MT
04-02	Transgene and NEC Bio Sign License Agreement for TG4050 Development in Head and Neck Cancer	CI
04-02	Transgene & NEC Bio sign license agreement to prepare next steps of development of TG4050 in head & neck cancer	RE
03-25	Danone, Dassault Systèmes, Orange... stocks to watch today in Paris
03-24	Transgene SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI